REVERA GEN
Dead / Abandoned — Abandoned — express abandonment (as of 29 Aug 2014)
What this means for you
This application is over — abandoned 28 Aug 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85466781
- Mark type
- Design + words
- Filed
- 08 Nov 2011
- Published for opposition
- 03 Jul 2012
- Abandoned
- 28 Aug 2014
- Attorney of record
- Dennis Bennett
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of neuromuscular disease
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- Reveragen Biopharma, Inc, Rockville, MD, US
- Reveragen Biopharma, Inc, Rockville, MD, US
Prosecution history
- 29 Aug 2014 — ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
- 29 Aug 2014 — ABANDONMENT - EXPRESS MAILED
- 28 Aug 2014 — TEAS EXPRESS ABANDONMENT RECEIVED
- 06 Mar 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2014 — SOU EXTENSION 3 GRANTED
- 26 Feb 2014 — SOU EXTENSION 3 FILED
- 26 Feb 2014 — SOU TEAS EXTENSION RECEIVED
- 07 Aug 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2013 — SOU EXTENSION 2 GRANTED
- 31 Jul 2013 — SOU EXTENSION 2 FILED
- 31 Jul 2013 — SOU TEAS EXTENSION RECEIVED
- 15 May 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2013 — SOU EXTENSION 1 GRANTED
- 28 Feb 2013 — SOU EXTENSION 1 FILED
- 10 May 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL